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SUMMARY – The aim of the study was to investigate knee cartilage thickness in polycystic 
ovary syndrome (PCOS) patients using ultrasonography and to assess the effects of sex steroids on 
osteoarthritis development. A total of 90 female patients were enrolled in the study, including 47 pa-
tients diagnosed with PCOS as study group and 43 patients admitted to our hospital for any other 
complaints as control group. Ultrasonographic evaluation of both knees was performed in all patients. 
The knee cartilage thickness was measured at lateral condyle, intercondylar area and medial condyle. 
The measurements were averaged for each region. The mean femoral cartilage thickness was greater in 
the study group compared with control group in all regions, with a statistically significant difference 
(p<0.005). In conclusion, we found PCOS patients to have greater mean cartilage thickness, support-
ing the possible effects of sex steroids on osteoarthritis development.
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Introduction
Osteoarthritis (OA) is a major health problem 
worldwide, and postmenopausal women are one of the 
most commonly affected groups1. Changes in sex ste-
roid hormone levels are a risk factor for development 
of OA2. Besides, it is a widespread disease in reproduc-
tive age with an incidence of 4%-12%3, increased an-
drogen levels caused by chronic anovulation, and un-
opposed estrogens are the major laboratory findings in 
polycystic ovary syndrome (PCOS)4. There are many 
studies pointing to the association of estrogen and an-
drogen hormone levels with cartilage formation in the 
literature, but the relationship of these hormone levels 
with development of OA is still unclear. As PCOS is a 
useful clinical sample to investigate the effect of estro-
gen and androgen hormone levels on cartilage devel-
opment, it may help us solve some pathophysiological 
questions on the development and treatment of OA.
Patients and Methods
Study population
Study subjects were recruited prospectively from 
female patients referred to gynecology and orthope-
dics departments from June to November, 2014. Pa-
tients diagnosed with PCOS were selected as study 
group. Control group included patients with various 
complaints, admitted to our radiology department for 
knee ultrasonography (US) examination. The diagno-
sis of PCOS was made according to the Rotterdam 
criteria of the American Society of Reproductive 
Medicine (ASRM)5, with evaluation of the presence of 
oligo/amenorrhea, clinical and biochemical signs of 
hyperandrogenism, and sonographic confirmation of 
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PCOS. To rule out the possible differences between 
the groups, all patients were questioned about chronic 
drug use, smoking, previous knee operations, or trau-
ma. Fertility status and demographic parameters of 
age, height and weight were also recorded. After care-
ful exclusion, 47 fertile women with PCOS and 43 
fertile women without PCOS, matched for age and 
body mass index (BMI), were enrolled in the study. All 
patients signed the informed consent form for partici-
pation in the study, which received institutional ethical 
approval and was conducted in line with the Declara-
tion of Helsinki principles.
Ultrasonographic measurements of femoral cartilage
Thickness of the femoral articular cartilage was 
measured by Aloca Prosound A6 (Hitachi Aloca 
Medical, USA) equipped with a 7.5 MHz linear array 
imaging probe. All measurements were performed by 
the same radiologists blinded for the patient clinical 
status while the patient was sitting comfortably on the 
examination table with the knees in maximum flexion. 
The probe was placed in the axial plane in the suprapa-
tellar area. Three midpoint measurements were taken 
from each knee, i.e. from the right lateral condyle, 
right intercondylar area, right medial condyle, left me-
dial condyle, left intercondylar area and left lateral 
condyle (Fig. 1).
compared using the χ2-test or Fisher exact test, where-
as Student’s t test, Mann-Whitney U test and Kruskal-
Wallis test were employed to compare the groups. A p 
value of less than 0.05 was considered statistically sig-
nificant.
Results
There was no significant difference between the 
groups in their demographic data (Table 1). Measure-
ments of 94 knees in the study group and 86 knees in 
the control group were analyzed. The mean femoral 
cartilage thickness at all measurement sites was higher 
in the study group compared with control group, yield-
ing statistical significance (p<0.05). These results are 
shown in Table 2.
Fig. 1. Ultrasonographic image demonstrating femoral 
cartilage measurements (suprapatellar axial view).
LCL = lateral condyle; IA = intercondylar area; MC = medial condyle
Statistical analysis
All statistical analyses were carried out using the 
SPSS software program. Categorical variables were 





RLC 2.00±0.41 1.76±0.33 0.003
RIA 2.12±0.51 1.99±0.45 0.002
RMC 2.15±0.51 2.01±0.22 0.004
LLC 2.03±0.31 1.812±0.55 0.003
LIA 2.06±0.28 1.87±0.33 0.002
LMC 2.20±0.41 2.01±0.12 0.003
p = level of significance; RLC = right lateral condyle; RIA = right 
intercondylar area; RMC = right medial condyle; LMC = left me-
dial condyle; LIA = left intercondylar area; LLC = left lateral 
 condyle
Table 1. Demographic data of patients
Study group Control group p
Age (yrs) 24±3.6 25.8±3.1 0.512
Height 64±2.9 174±3.1 0.684
Weight 65±3.2 178±4.1 0.612
BMI 22±1.9 23±2.1 0.618
BMI = body mass index; p = level of significance
Discussion
Polycystic ovary syndrome is a common endocri-
nopathy in reproductive age with an incidence of 4% 
to 7%6, reaching 15% in infertile patients7. The main 
biochemical findings are unopposed levels of estradiol 
and higher luteinizing hormone/follicle-stimulating 
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hormone ratios, in addition to androgen excess, and 
these endocrine disorders result in chronic anovula-
tion8. The anovulation induces hormonal imbalance 
and the patient clinical status enters a vicious circle. In 
this respect, we believed that patients diagnosed with 
PCOS might provide an appropriate clinical sample to 
investigate the possible effects of sex steroids on carti-
lage thickness and OA formation.
Tsai and Liu9 report that sex steroids have physio-
logical effects on cartilage involvement, and Abu et 
al.10 showed that there were sex steroid receptors lo-
cated on articular chondrocytes. Previous data indicate 
that estrogen may conflict with osteoclast and osteo-
blast coupling and thus the cartilage turnover; it also 
affects the osteoblast activity on subchondral bone and 
cartilage via second messengers such as transforming 
growth factor-beta, cartilage-inducing factor A, inter-
leukin-6, and insulin-like growth factor I and II9,11-13. 
Additionally, previous data suggest that estrogen re-
placement therapy used for more than 5 years resulted 
in increased knee cartilage volume13, and exogenous 
estrogen was shown to exert some beneficial effects on 
OA treatment in animal models14,15. However, it is 
known that men have greater cartilage volume com-
pared with women; we could not assess androgen ef-
fects on cartilage volume because of the study popula-
tion selection. None of our patients showed an andro-
genic phenotype and further studies are needed to ex-
plore the possible impact of androgens on the knee 
cartilage in PCOS. Another limitation of our study 
was that our patients had higher BMI values. Since 
higher weight has an important role in OA formation, 
our results could not be interpreted as suggesting that 
PCOS patients had a lower risk of developing OA 
later in life. We believe that our ongoing long-term 
follow-up study of PCOS patients will provide answer 
to this problem.
Since the patients diagnosed with PCOS have 
greater mean cartilage thickness, we are inclined to be-
lieve that the pathophysiological mechanism is based 
on increased androgen and estrogen hormone values in 
these patients. Hormone replacement treatment may 
be useful for OA patients, but further studies are need-
ed to prove our hypothesis.
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Sažetak
ULTRAZVUČNA PROCJENA DEBLJINE BEDRENE HRSKAVICE  
U BOLESNICA SA SINDROMOM POLICISTIČNIH JAJNIKA
M. Kara, A. Okur i H.I. Serin
Cilj istraživanja bio je ultrazvučno procijeniti debljinu hrskavice koljena u bolesnica sa sindromom policističnih jajnika 
(SPCJ) i učinak spolnih hormona na razvoj osteoartritisa. U istraživanje je bilo uključeno ukupno 90 žena, tj. 47 bolesnica s 
dijagnozom SPCJ kao ispitna skupina i 43 bolesnice primljene na odjel zbog drugih tegoba kao kontrolna skupina. Ultra-
zvučna procjena obaju koljena učinjena je u svih bolesnica. Debljina hrskavice koljena mjerena je u lateralnom kondilu, inter-
kondilarnom području i medijalnom kondilu te je izračunat prosjek mjerenja za svaku regiju. Srednja debljina koljenske 
 hrskavice bila je veća u ispitnoj skupini u usporedbi s kontrolnom skupinom u svim regijama, a razlika je bila statistički 
značajna (p<0,005). Dakle, utvrđeno je da bolesnice sa SPCJ imaju veću srednju debljinu koljenske hrskavice, što govori u 
prilog mogućeg utjecaja spolnih hormona na razvoj osteoartritisa.
Ključne riječi: Hrskavica, zglobna; Hrskavica, zglobna – dijagnostičko snimanje; Policistični ovarij, sindrom; Ženska osoba; 
Koljenski zglob; Osteoartritis koljena
